INTRODUCTION
Hemolytic disease of the newborn (HDN) secondary to anti-D has dramatically declined with the widespread prophylactic use of anti-D antibody preparation. Consequently, HDN attributed to other blood groups has become relatively more significant. DÀ À blood group is quite rare and was first described by Race and Sanger 1 in 1950 with the absence of C/c and E/e antigens. We report the successful management of a case of hemolytic disease and hydrops fetalis secondary to anti-Rh 17 antibodies in a woman with the rare DÀ À phenotype.
CASE REPORT
A 34-year-old Caucasian (gravida 2, term 1, premature 0, abortion 0, livebirth 1) woman had negative antenatal tests for syphilis, hepatitis B and HIV. She was immune to rubella and her blood group was A,D+. At 12 weeks of gestation, she was identified with an antibody against high-frequency red blood cell (RBC) antigen Rh 17; her direct Coombs test was negative. Detailed typing and antibody identification showed that she had a DÀ À Rh phenotype with an anti-Rh 17 titer of 512. Her mother's and father's RBC phenotypes were O,D+c+e+ and A,D+C+e+, respectively, and their genotypes were Dce/DÀ À and DCe/ À À À. Her husband's RBC phenotype was O,D+C+c+E+e+. Her first pregnancy had been uneventful and yielded a normal healthy girl with no evidence of HDN or neonatal jaundice. However, she had been transfused postpartum with 2 U of blood.
At 20 weeks of gestation, the ultrasonogram showed mild to moderate polyhydramnios, a ''double bubble sign'' consistent with duodenal atresia, and no signs of fetal hydrops. Fetal chromosomal analysis revealed a normal 46XY karyotype. Serial amniocentesis was done for delta OD 450 spectrophotometric analysis to evaluate the presence and degree of fetal RBC destruction. At 30 weeks of gestation, the delta OD 450 (0.16) plotted on the upper zone II of the Liley graph and, 5 days later, repeat testing plotted in mid zone III. AntiRh 17 antibody titer had risen at that time to 4000. Despite the high delta OD 450 and high antibody titer, no evidence of fetal hydrops or anemia was present on ultrasonogram, including middle cerebral artery Doppler study. We considered that the high Á OD 450 analysis could be due to hemolysis or the bowel obstruction. Pulmonary maturation was induced by administration of betamethasone. At 33 weeks of gestation, Doppler study of the middle cerebral arteries showed increased peak systolic flow (>1.5 multiples of the median) denoting progressive fetal anemia. The ultrasonogram also revealed fetal hydrops.
The baby was delivered through cesarean section with Apgar scores of 4 and 7 at 1 and 5 minutes, respectively. The baby was hydropic and pale. The baby was intubated and received positive pressure ventilation with 100% oxygen. Birth weight was 2121 g (75th percentile), head circumference 31 cm (50th percentile), and length 44 cm (50th percentile). The initial hemoglobin and hematocrit were 6 g/dl and 23%, respectively, white cell count 23Â10 3 /l, platelet count 100Â10 3 /l, and reticulocytic count 21%. The RBC phenotype was O,D+C+e+. Cord bilirubin concentration was 7.1 mg/dl with a We report the successful management of a case of hemolytic disease and hydrops fetalis secondary to anti Rh 17 antibodies in a woman with the rare D À À phenotype. We discuss the efficacy of intravenous immunoglobulins in treating hemolytic disease of the newborn infant. Perinatal/Neonatal Case Presentation
direct value of 1 mg/dl, total protein concentration was 3.1 g/dl, and albumin 2.3 g/dl. A partial red cell exchange was performed using O, DÀ À frozen packed RBCs (20 ml/kg) following which the hemoglobin concentration and hematocrit were 14 g/dl and 41%, respectively. Surfactant was given and high-frequency ventilation initiated; umbilical artery and vein catheters were placed. Dopamine was started to treat systemic hypotension. Two chest tubes were inserted to drain bilateral pleural effusions, and a third chest tube was inserted to evacuate a pneumothorax. The baby was given phenobarbital, intravenous immunoglobulin (IVIG) (0.5 g/kg) and phototherapy. Another exchange transfusion was done using O, DÀ À frozen packed cells reconstituted in fresh frozen plasma, and a second dose of IVIG was given. Following the second exchange transfusion, hemoglobin concentration and hematocrit increased to 19 g/dl and 54%, respectively, total serum bilirubin 5.3 mg/dl, direct bilirubin 0.5 mg/dl, and antibody titer 256. The baby developed pulmonary hypertension, which responded to nitric oxide. Due to the limited availability of the DÀ À blood type, erythropoietin was started at a dose of 200 U/kg daily to minimize the need for transfusion. Hemoglobin and hematocrit remained above 15 g/dl and 45% without additional transfusions (except electively prior to surgery). The baby underwent ligation of a symptomatic patent ductus arteriosus and correction of duodenal atresia and malrotation. The baby developed cholestasis attributed to inspissated bile and prolonged parenteral nutrition.
DISCUSSION
Although HDN due to anti-Rh 17 antibodies has been reported at least twice, 2,3 IVIG has not been used in these patients. The DÀ À phenotype is a very rare condition, in which RBCs lack expression of all the Rh antigens (Cc Ee) except for the D antigen. Individuals with Rh deletions such as DÀ À have no Hr o antigen, and become immunized when exposed to the high-frequency antigen during pregnancy or with blood transfusion. 4 Anti-Hr o antibodies are complex immunoglobulins directed against an ill-defined highfrequency antigen. The lack of RhCE-encoded proteins is thought to release sites within the Rh complex, associated with overexpression of the D antigen in the RBC membrane of DÀ À individuals. 5 Two genes, present on chromosome 1, encode Rh proteins: the RhD gene coding for the D antigen and the RhCcEe gene coding for Cc Ee antigens. 5 Little is known about the defects responsible for the lack of Cc Ee antigen expression in the gene complex defined as DÀ À.
Our patient inherited the DÀ À haplotype from her mother, which encodes the elevated expression of the D antigen, and inherited a null allele from her father. Others report that lack of Cc Ee antigens originates from different alteration of the RhCE gene and that the Rh locus of DÀ À individuals might be composed of a normal RhD and a silent RhCE gene, as is also found in the Rh null amorph chromosome. 5 Our patient most likely was sensitized to Rh 17 antigen when she was transfused after her first pregnancy. During the current pregnancy, maternal sensitization was detected at 12 weeks of gestation by routine antibody screen and maternal. Antibodies were identified as anti-Rh 17. In addition, her RBCs expressed a larger amount of D antigen.
The significance of increased OD 450 measurements was unclear during the second pregnancy because gastrointestinal obstruction distal to Vater's ampulla may raise the concentration of bilirubin in the amniotic fluid above normal values. 6 Therefore, management of the pregnancy was based on serial assessments of fetal ultrasonograms and Doppler studies of the middle cerebral artery. 7 Owing to the limited availability of donor DÀ À blood, blood sampling from the infant was kept at a minimum and erythropoietin was administered. High-dose IVIG was utilized to inhibit hemolysis before and following the exchange transfusion. High-dose IVIG has been used in neonates with HDN for several years in some countries. 8 -13 The efficacy of IVIG for HDN has been assessed in a few controlled trials, 8 -13 including three randomized controlled clinical trials.
11 -13 IVIG appears effective in limiting the need for exchange transfusion in HDN, and is not associated with recognized toxicity. The response to IVIG may be dependent on the severity of the HDN 8, 9 and on the number of doses administered. 10 
